Dimensional Fund Advisors’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $68.1M | Buy |
1,468,508
+100,429
| +7% | +$3.61M | 0.01% | 1418 |
|
|
2026
Q1 | $33.5M | Buy |
1,368,079
+152,267
| +13% | +$3.61M | 0.01% | 1712 |
|
|
2025
Q4 | $30.2M | Sell |
1,215,812
-18,909
| -2% | -$502K | 0.01% | 1771 |
|
|
2025
Q3 | $35M | Sell |
1,234,721
-27,432
| -2% | -$743K | 0.01% | 1713 |
|
|
2025
Q2 | $31.4M | Buy |
1,262,153
+144,386
| +13% | +$4.07M | 0.01% | 1760 |
|
|
2025
Q1 | $34.7M | Buy |
1,117,767
+72,227
| +7% | +$2.41M | 0.01% | 1665 |
|
|
2024
Q4 | $33M | Buy |
1,045,540
+101,192
| +11% | +$4.81M | 0.01% | 1753 |
|
|
2024
Q3 | $54.7M | Buy |
944,348
+12,993
| +1% | +$638K | 0.01% | 1453 |
|
|
2024
Q2 | $37.8M | Buy |
931,355
+103,608
| +13% | +$4.11M | 0.01% | 1637 |
|
|
2024
Q1 | $34.8M | Buy |
827,747
+59,227
| +8% | +$2.31M | 0.01% | 1693 |
|
|
2023
Q4 | $29.4M | Buy |
768,520
+59,895
| +8% | +$1.99M | 0.01% | 1781 |
|
|
2023
Q3 | $21.9M | Buy |
708,625
+105,565
| +18% | +$3.64M | 0.01% | 1870 |
|
|
2023
Q2 | $19.1M | Buy |
603,060
+108,239
| +22% | +$3.71M | 0.01% | 1956 |
|
|
2023
Q1 | $18M | Buy |
+494,821
| New | +$17.3M | 0.01% | 1959 |
|
|
2022
Q3 | $14.8M | Sell |
379,853
-17,770
| -4% | -$813K | 0.01% | 1979 |
|
|
2022
Q2 | $15.3M | Sell |
397,623
-3,617
| -0.9% | -$138K | 0.01% | 2003 |
|
|
2022
Q1 | $19.4M | Buy |
401,240
+22,761
| +6% | +$1.17M | 0.01% | 1983 |
|
|
2021
Q4 | $27.8M | Buy |
378,479
+27,416
| +8% | +$2.25M | 0.01% | 1800 |
|
|
2021
Q3 | $32M | Buy |
351,063
+105,825
| +43% | +$9M | 0.01% | 1745 |
|
|
2021
Q2 | $15.4M | Buy |
245,238
+132,285
| +117% | +$4.89M | ﹤0.01% | 2171 |
|
|
2021
Q1 | $3.06M | Buy |
112,953
+27,886
| +33% | +$671K | ﹤0.01% | 2738 |
|
|
2020
Q4 | $1.55M | Buy |
85,067
+47,294
| +125% | +$850K | ﹤0.01% | 2878 |
|
|
2020
Q3 | $678K | Hold |
37,773
| – | – | ﹤0.01% | 3007 |
|
|
2020
Q2 | $623K | Buy |
37,773
+1,664
| +5% | +$26.2K | ﹤0.01% | 3036 |
|
|
2020
Q1 | $467K | Hold |
36,109
| – | – | ﹤0.01% | 3068 |
|
|
2019
Q4 | $665K | Sell |
36,109
-1,641
| -4% | -$27.2K | ﹤0.01% | 3089 |
|
|
2019
Q3 | $665K | Hold |
37,750
| – | – | ﹤0.01% | 3096 |
|
|
2019
Q2 | $631K | Hold |
37,750
| – | – | ﹤0.01% | 3150 |
|
|
2019
Q1 | $692K | Buy |
37,750
+5,508
| +17% | +$106K | ﹤0.01% | 3109 |
|
|
2018
Q4 | $640K | Buy |
32,242
+19,561
| +154% | +$366K | ﹤0.01% | 3105 |
|
|
2018
Q3 | $280K | Buy |
+12,681
| New | +$267K | ﹤0.01% | 3265 |
|
Other funds holding ASTH
3C
Dimensional Fund Advisors's ASTH Position: Q2 2026 in Review
Dimensional Fund Advisors increased its Astrana Health (ASTH) stake by 7.3% in Q2 2026, buying an estimated $3.61M and bringing the position to 1,468,508 shares worth $68.1M. The position accounts for 0.01% of the portfolio, ranked #1418.
Dimensional Fund Advisors first reported a position in ASTH in Q3 2018 and has held it in 31 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Dimensional Fund Advisors held 1,468,508 shares of Astrana Health worth $68.1M as of Q2 2026.
- Dimensional Fund Advisors bought 100,429 Astrana Health shares in Q2 2026, an estimated $3.61M.
- Astrana Health made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1418 holding.
- Dimensional Fund Advisors first reported a position in Astrana Health in Q3 2018 and has held it in 31 quarters since.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.